Your browser doesn't support javascript.
loading
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative.
Allen, Casey J; Eska, Jarrod S; Thaker, Nikhil G; Feeley, Thomas W; Kaplan, Robert S; Huey, Ryan W; Tzeng, Ching-Wei D; Lee, Jeffrey E; Frank, Steven J; Aloia, Thomas A; Gottumukkala, Vijaya; Katz, Matthew H G.
Afiliación
  • Allen CJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Eska JS; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thaker NG; Department of Radiation Oncology, Arizona Oncology, Tucson, Arizona.
  • Feeley TW; Institute for Strategy and Competitiveness, Harvard Business School, Boston, Massachusetts.
  • Kaplan RS; Institute for Strategy and Competitiveness, Harvard Business School, Boston, Massachusetts.
  • Huey RW; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tzeng CD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Frank SJ; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Aloia TA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gottumukkala V; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Anesthesia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: mhgkatz@mdanderson.org.
J Surg Res ; 262: 115-120, 2021 06.
Article en En | MEDLINE | ID: mdl-33561722
ABSTRACT

BACKGROUND:

There remains no tool to quantify the total value of comparative processes in health care. Hospital administrative data sets are emerging as valuable sources to evaluate performance. Thus, we use a framework to simultaneously assess multiple domains of value associated with an enhanced recovery initiative using national administrative data. MATERIALS AND

METHODS:

Risk-stratified clinical pathways for patients undergoing pancreatic surgery were implemented in 2016 at our institution. We used a national administrative database to characterize changes in value associated with this initiative. Value metrics assessed included in-hospital mortality, complication rates, length of stay (LOS), 30-day readmission rates, and institutional costs. We compared our performance with other hospitals both before and after implementation of the pathways. Metrics were graphed on radar charts to assess overall value.

RESULTS:

22,660 cases were assessed. Comparing 75 cases at our institution and 5520 cases at all other hospitals before pathway implementation, mean in-hospital LOS was 9.6 versus 10.8 d, in-hospital mortality was 0.0% versus 1.9%, mean costs were $23,585 versus $21,387, 30-day readmission rates were 1.3% versus 7.4%, and complication rates were 8.0% versus 11.2%, respectively. Comparing 334 cases at our institution and 16,731 cases at all other hospitals after pathway implementation, mean in-hospital LOS was 7.7 versus 10.3 d, in-hospital mortality was 0.3% versus 1.6%, mean costs were $19,428 versus $22,032, 30-day readmission rates were 6.6% versus 7.5%, and complication rates were 6.3% versus 10.3%, respectively. Notably, LOS and institutional costs were reduced at our institution after implementation of the enhanced clinical care pathways. Our costs were higher than comparators before implementation, but lower than comparators after implementation.

CONCLUSIONS:

Herein, we used an analytic framework and used national administrative data to assess the value of an enhanced care initiative as benchmarked with data from other hospitals. We thus illustrate how to identify and measure opportunities for targeted improvements in health care delivery. We also recognize the limitations of the use of administrative data in a comprehensive assessment of value in health care.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Páncreas / Atención a la Salud Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Surg Res Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Páncreas / Atención a la Salud Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Surg Res Año: 2021 Tipo del documento: Article